Can Duloxetine Cause a Rash?
Yes, duloxetine can cause rash, including severe and potentially life-threatening skin reactions such as Stevens-Johnson syndrome (SJS) and erythema multiforme, though these serious reactions are rare. 1
Severity and Types of Skin Reactions
The FDA drug label explicitly warns about severe skin reactions with duloxetine 1. The reporting rate of Stevens-Johnson syndrome associated with duloxetine exceeds the general population background incidence rate (1-2 cases per million person-years), though this is likely underestimated due to underreporting 1.
Duloxetine should be discontinued immediately at the first appearance of:
- Skin blisters
- Peeling rash
- Mucosal erosions (sores in the mouth)
- Hives
- Any other signs of hypersensitivity if no other cause can be identified 1
Clinical Context
While the FDA label and guidelines discussing duloxetine's adverse effects mention multiple common side effects (nausea, headache, dry mouth, dizziness, insomnia, sweating) 2, 3, 4, skin reactions are specifically highlighted as a serious adverse effect requiring immediate medical attention 1.
In clinical trials and post-marketing surveillance, the most frequently reported adverse events were gastrointestinal and neurological symptoms, not dermatological 4, 5, 6. However, the specific warning about severe skin reactions in the FDA label indicates these are recognized, serious, albeit uncommon complications.
Important Clinical Pitfalls
Do not confuse duloxetine-induced rash with:
- Facial flushing (which has been reported separately and may occur with inappropriate administration, such as opening capsules) 7
- Common mild adverse effects like sweating or hyperhidrosis 4
Critical action point: Any patient developing skin blisters, peeling rash, or mucosal erosions while on duloxetine requires immediate discontinuation and may need hospitalization, as these reactions can be life-threatening 1.
The evidence clearly establishes that while duloxetine is generally well-tolerated with most adverse effects being mild to moderate 4, severe skin reactions represent a recognized and serious risk that requires immediate clinical intervention.